Search Results

Search Results

topic

audience

Results returned for SGLT2 inhibitorfrom all of CDC.gov

Also try: salts inhibitor, salts inhibitors, salts inhibition

The number of adults with CKD stages 1–4 was estimated by applying the overall percentage to the 2019 US Census population aged 18 years and older. Blood pressure–lowering medicines included angiotensin-converting enzyme inhibitorsRead more
Centers for Disease Control and Prevention (CDC) : CKD SurveillanceRead more
Interventions to improve care and better manage ESKD risk factors among persons with diabetes and hypertension, along with increased use of therapeutic agents such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor…Read more
CS -338890 May 2023 https://www.cdc.gov/kidneydisease/publications-resources/CKD-national-facts.html Treatment to Lower Blood Sugar† • Newer blood sugar–lowering medicines, such as GLP1 receptor agonists, SGLT2 inhibitors,…Read more
Clinical Overview of RSV
Last Updated: Apr 2025
Diabetes mellitus complicated by chronic kidney disease, neuropathy, retinopathy, or other end-organ damage, or requiring treatment with insulin or sodium-glucose cotransporter-2 (SGLT2) inhibitor. Neurologic or neuromuscular…Read more
CS -338890 May 2023 https://www.cdc.gov/kidneydisease/publications-resources/CKD-national-facts.html Treatment to Lower Blood Sugar† • Newer blood sugar–lowering medicines, such as GLP1 receptor agonists, SGLT2 inhibitors,…Read more
Hospitalization rates for diabetic ketoacidosis have been increasing in the United States since 2009 among all age groups.Read more
Diabetes mellitus complicated by chronic kidney disease, neuropathy, retinopathy, or other end-organ damage, or requiring treatment with insulin or sodium-glucose cotransporter-2 (SGLT2) inhibitor. Neurologic or neuromuscular…Read more
[PDF]CDC Factsheet
Last Updated: Apr 2025
Factors associated with increased risk* for severe RSV disease include: Chronic lung disease Chronic cardiovascular disease End-stage renal disease or dependence on dialysis Diabetes mellitus with end- organ damage or requiring insulin…Read more
Interventions to improve care and better manage ESKD risk factors among persons with diabetes and hypertension, along with increased use of therapeutic agents such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor…Read more

Please use the search area above.

Please use the search area above.